(Q40122794)

English

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood

scientific article published on January 1, 1978

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood (English)

reason for preferred rank

most precise value

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. II. Epstein-Barr virus studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202404

3 January 2023

Epstein–Barr virus

0 references

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

5

object named as

T. Bakacs

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202404

3 January 2023

author name string

L. Einhorn

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202404

3 January 2023

M. Steinitz

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202404

3 January 2023

E. Yefenof

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202404

3 January 2023

I. Ernberg

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202404

3 January 2023

G. Klein

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A202404

3 January 2023

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=202404

3 January 2023

publication date

1 January 1978

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:0008874978901259?httpAccept=text/xml

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

https://api.elsevier.com/content/article/PII:0008874978901259?httpAccept=text/plain

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Cellular Immunology

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

35

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

43-58

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Epstein-Barr virus (EBV) receptors, complement receptors, and EBV infectibility of different lymphocyte fractions of human peripheral blood. I. Complement receptor distribution and complement binding by separated lymphocyte subpopulations

1

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Sensitivity of Epstein-Barr virus (EBV) producer and non-producer human lymphoblastoid cell lines to superinfection with EB-virus

2

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

7

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

An EBV-Genome-Negative Cell Line Established from an American Burkitt Lymphoma; Receptor Characteristics. EBV Infectibility and Permanent Conversion into EBV-Positive Sublines by <i>in vitro</i> Infection

8

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Surface markers on human B and T lymphocytes. VIII. Association between complement and Epstein-Barr virus receptors on human lymphoid cells

9

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Surface markers on human B- and T-lymphocytes. IX. Two-color immunofluorescence studies on the association between EBV receptors and complement receptors on the surface of lymphoid cell lines

10

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Demonstration of complement receptors on lymphoblastoid cells by radiolabeled antibodies and in situ autoradiography

11

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Relationships between complement activation, complement binding, and EBV absorption by human hematopoietic cell lines

12

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Surface markers on human B and T lymphocytes. II. Presence of Epstein-Barr virus receptors on B lymphocytes

13

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Epstein-Barr virus binding sites on lymphocyte subpopulations and the origin of lymphoblasts in cultured lymphoid cell lines and in the blood of patients with infectious mononucleosis

14

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Induction of cellular DNA synthesis in human leukocytes by Epstein-Barr virus

15

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Presence of Epstein-Barr virus receptors, but absence of virus penetration, in cells of an Epstein-Barr virus genome-negative human lymphoblastoid T line (Molt 4)

18

1 reference

10.1016/0008-8749(78)90125-9

https://api.crossref.org/works/10.1016/0008-8749(78)90125-9

3 January 2023

Identifiers

10.1016/0008-8749(78)90125-9

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40122794&oldid=1801412386"